Journal
NATURE REVIEWS CANCER
Volume 9, Issue 8, Pages 537-549Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2694
Keywords
-
Categories
Funding
- the Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2007-60575]
- Fundacion La Caixa, MICINN/ISCIII-RTICC [RD06/0020/0083]
- European Commission FP7 programme [223151]
- BBVA
Ask authors/readers for more resources
Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) family members function in a cell context-specific and cell type-specific manner to integrate signals that affect proliferation, differentiation, survival and migration. Consistent with the importance of these events in tumorigenesis, JNK and p38 MAPK signalling is associated with cancers in humans and mice. Studies in mouse models have been essential to better understand how these MAPKs control cancer development, and these models are expected to provide new strategies for the design of improved therapeutic approaches. In this Review we highlight the recent progress made in defining the functions of the JNK and p38 MAPK pathways in different cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available